Home management of heart issues in scleroderma
Part of Lungs & breathing, Skin clinical trials.
This study tests whether people with systemic sclerosis (scleroderma) and pulmonary arterial hypertension (PAH) can safely monitor their heart health at home using a smartphone or other internet-connected device. If you have PAH and are comfortable using technology, this trial may help make care more convenient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with systemic sclerosis (scleroderma) by a doctor.
- You have pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs.
- You can understand and follow study instructions, including filling out online questionnaires.
- You have internet access and are comfortable using a smartphone, tablet, or computer.
- You are able to walk safely (with or without a walking aid) and have not had recent surgery, heart attack, or stroke in the last 8 weeks.
- You do not have severe organ damage (like advanced heart, kidney, or lung disease), active cancer, or uncontrolled blood pressure or heart rate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a home-based exercise program to see if it improves quality of life for people with systemic sclerosis (scleroderma). You would do the exercises on your own, and researchers would check in with you using email questionnaires.
This trial tests if a device called Apollo can help reduce fatigue and Raynaud's symptoms and improve quality of life in people with scleroderma (systemic sclerosis). You would use the device at home and track your symptoms using a smartphone app.
This trial tests a home-based exercise program delivered through a smartphone app for people with pulmonary arterial hypertension (PAH), a condition where the blood vessels in the lungs are narrowed, making the heart work harder. The program aims to improve physical function and quality of life through guided telerehabilitation.
This study uses artificial intelligence to find better ways to screen for pulmonary arterial hypertension (a type of high blood pressure in the lungs) in people with systemic sclerosis (scleroderma). The goal is to catch the condition earlier so treatment can start sooner.
This trial tests whether people with lung disease caused by a rheumatic condition can safely manage their care at home using a smartphone or tablet. It aims to see if home monitoring is as effective as in-person visits for keeping your lungs healthy.
This study tests whether a home-based exercise program, guided by a smartphone app, can improve your daily life and heart function if you have pulmonary hypertension. You will use a wearable device to track your activity and receive remote support from a medical team.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.